Regenity Biosciences, formerly known as Collagen Matrix, specializes in the development of bioresorbable and biocompatible materials aimed at enhancing tissue and bone repair. The company leverages advanced proprietary technology platforms to create innovative medical solutions that support the body’s natural healing processes. Their product offerings include a range of medical-grade biomaterials designed for various applications, including dental, ENT, and orthopedic surgeries. By focusing on regenerative science, Regenity aims to transform tissue healing from concept to commercialization, ensuring that their products meet the urgent needs of patients and healthcare providers.

In addition to their core focus on regenerative technologies, Regenity also emphasizes collaboration and creativity in their approach to product development and contract manufacturing. With over 25 years of experience, the company provides comprehensive support to medical technology clients, helping them accelerate time-to-market and navigate regulatory approvals. Their commitment to integrity and determination drives the continuous improvement of their offerings, making them a sought-after partner in the medical device industry. The recent acquisition of Polyganics further enhances their capabilities, expanding their portfolio of versatile synthetic polymers for tissue repair across multiple surgical disciplines.

United States

Collagen Matrix is a biotechnology company that specializes in developing medical devices and products for regenerative medicine using collagen as a key component.

Collagen matrix

Company Details